CD14 is a ligand for the integrin α4β1

FEBS Letters

Volumn 581, Issue 4, 2007, Pages 757-763

  Humphries, Jonathan D ^a   Humphries, Martin J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

CD14; Cell adhesion; Integrin

Indexed keywords

CD14 ANTIGEN; VASCULAR CELL ADHESION MOLECULE 1; VERY LATE ACTIVATION ANTIGEN 4;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL ADHESION; CELL STRAIN K 562; CELL TYPE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; HYPOTHESIS; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INDUCTION; PROTEIN INTERACTION; RAT;

ANIMALS; ANTIGENS, CD14; CELL ADHESION; CERCOPITHECUS AETHIOPS; CHROMATOGRAPHY, AFFINITY; COS CELLS; HUMANS; INTEGRIN ALPHA4BETA1; INTEGRINS; JURKAT CELLS; K562 CELLS; LIGANDS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; PROTEIN BINDING; RECOMBINANT PROTEINS;

EID: 33846815180     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.01.038     Document Type: Article

References (39)

1. Hynes R.O. Integrins: bidirectional, allosteric signalling machines. Cell 110 (2002) 673-687
2. Humphries M.J., McEwan P.A., Barton S.J., Buckley P.A., Bella J., and Mould A.P. Integrin structure: heady advances in ligand binding, but activation still makes the knees wobble. Trends Biochem. Sci. 28 (2003) 313-320
3. Travis M.A., Humphries J.D., and Humphries M.J. An unraveling tale of how integrins are activated from within. Trends Pharmacol. Sci. 24 (2003) 192-197
4. Geiger B., Bershadsky A., Pankov R., and Yamada K.M. Transmembrane extracellular matrix-cytoskeleton crosstalk. Nat. Rev. 2 (2001) 793-805
5. Xiong J.P., Stehle T., Zhang R., Joachimiak Frech M., Goodman S.L., and Arnaout M.A. Crystal structure of the extracellular segment of integrin alpha v beta 3 in complex with an Arg-Gly-Asp ligand. Science 296 (2002) 151-155
6. Rose D.M., Han J., and Ginsberg M.H. α4 integrins and the immune response. Immunol. Rev. 186 (2002) 118-124
7. Humphries J.D., Byron A., and Humphries M.J. Integrin ligands at a glance. J. Cell Sci. 119 (2006) 3901-3903
8. Elices M.J., Osborn L., Takada Y., Crouse C., Luhowskyi S., Hemler M.H., and Lobb R.R. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60 (1990) 577-584
9. Wayner E.A., Garcia-Pardo A., Humphries M.J., McDonald J.A., and Carter W.G. Identification and characterisation of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J. Cell Biol. 109 (1989) 1321-1330
10. Mould A.P., Wheldon L.A., Komoriya A., Wayner E.A., Yamada K.M., and Humphries M.J. Affinity chromatographic isolation of the melanoma adhesion receptor for the IIICS region of fibronectin and its identification as the integrin α4β1. J. Biol. Chem. 265 (1990) 4020-4024
11. Newham P., Craig S.E., Seddon G.N., Schofield N.R., Rees A., Edwards R.M., Jones E.Y., and Humphries M.J. α4 Integrin binding interfaces on VCAM-1 and MAdCAM-1. Integrin binding footprints identify accessory binding sites that play a role in integrin specificity. J. Biol. Chem. 272 (1997) 19429-19440
12. Bayless K.G., Meininger G.A., Scholtz J.M., and Davis G.E. Osteopontin is a ligand for the alpha4beta1 integrin. J. Cell Sci. 111 (1998) 1165-1174
13. Li Z., Calzada M.J., Sipes J.M., Cashel J.A., Krutzsch H.C., Annis D.S., Mosher D.F., and Roberts D.D. Interactions of thrombospondins with alpha4beta1 integrin and CD47 differentially modulate T cell behavior. J. Cell Biol. 157 (2002) 509-519
14. Sheppard D. In vivo functions of integrins: lessons from null mutations in mice. Matrix Biol. 19 (2000) 203-209
15. Ferrero E., Hsieh C.-L., Francke U., and Goyert S.M. CD14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes. J. Immunol. 145 (1990) 331-336
16. Simmons D.L., Tan S., Tenen D.G., Nicholson-Weller A., and Seed B. Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood 73 (1989) 284-289
17. Kim J.-I., Lee C.J., Jin M.S., Lee C.-H., Paik S.-G., Lee H., and Lee J.-O. Crystal structure of CD14 and its implications for lipopolysaccaride signalling. J. Immunol. 280 (2005) 11347-11351
18. Landmann R., Link S., Sansano S., Rajacic Z., and Zimmerli W. Soluble CD14 activates monocytic cells independently of lipopolysaccharide. Infect. Immun. 66 (1998) 2264-2271
19. Jersmann H.P.A. Time to adandon dogma: CD14 is expressed by non-myeloid lineage cells. Immunol. Cell Biol. 83 (2005) 462-467
20. Lloyd K.L., and Kubes P. GPI linked endothelial CD14 contributes to the detection of LPS. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H473-H481
21. Antal-Szalmas P. Evaluation of CD14 in host defence. Eur. J. Clin. Invest. 30 (2000) 167-179
22. Triantafilou M., and Triantafilou K. The dynamics of LPS recognition: complex orchestration of multiple receptors. J. Endotoxin Res. 11 (2005) 5-11
23. Triantafilou M., and Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 23 (2002) 301-304
24. Devitt A., Moffatt O.D., Raykundalia C., Capra J.D., Simmons D.L., and Gregory C.D. Human CD14 mediated recognition and phagocytosis of apoptotic cells. Nature 392 (1998) 505-509
25. Gregory C.D., and Devitt A. CD14 and apoptosis. Apoptosis 4 (1999) 11-20
26. Petty H.R., and Todd R.F. Integrins as promiscuous signal transduction devices. Immunol. Today 17 (1996) 209-212
27. Tudor K.-S.R.S., Deem T.L., and Cook-Mills J.M. Novel of α4-integrin ligands on an endothelial cell line. Biochem. Cell Biol. 78 (2000) 99-113
28. Mould A.P., Garratt A.N., Askari J.A., Akiyama S.K., and Humphries M.J. Identification of a novel ani-integrin monoclonal antibody that recognises a ligand-induced binding site epitope on the β1 subunit. FEBS Lett. 363 (1995) 118-122
29. Humphries J.D., Schofield N.R., Mostafavi-Pour Z., Green L.G., Garratt A.N., Mould A.P., and Humphries M.J. Dual functionality of the anti-β1 integrin antibody, 12G10, exemplifies agonistic signalling from the ligand binding pocket of integrin adhesion receptors. J. Biol. Chem. 280 (2005) 10234-10243
30. Coe A.P.F., Askari J.A., Kline A.D., Robinson M.K., Kirby H., Stephens P.E., and Humphries M.J. Generation of a minimal α5β1 integrin-Fc fragment. J. Biol. Chem. 276 (2001) 35854-35866
31. Hazeki K., Masuda N., Funami K., Sukenobu A., Matsumoto M., Akira S., Takeda K., Seya T., and Hazeki O. Toll-like receptor-mediated tyrosine phosphorlyation of paxillin via MyD88-dependent and -independent pathways. Eur. J. Immunol. 33 (2003) 740-747
32. Triantafilou M., Miyake K., Golenbock D.T., and Triantafilou K. Mediators of innate recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 115 (2002) 2603-2611
33. Leitinger B., and Hogg N. The involvement of lipid rafts in the regulation of integrin function. J. Cell Sci. 115 (2002) 963-972
34. Beekhuizen H., Blokland I., Corsel-van Tilberg A., Koning F., and van Furth R. CD14 contributes to the adherence of human monocytes to cytokine-stimulated endothelial cells. J. Immunol. 147 (1991) 3761-3767
35. Kobe B., and Kajava A.V. The leucine-rich repeat as a protein recognition motif. Curr. Opin. Struct. Biol. 11 (2001) 725-732
36. Guidetti G., Bertoni A., Viola M., Tira E., Balduini C., and Torti M. The small proteoglycan decorin supports adhesion and activation of human platelets. Blood 100 (2002) 1707-1714
37. Zarewych D.M., Kindzelskii A.L., Todd R.F., and Petty H.R. LPS induces CD14 association with complement receptor type 3, which is reversed by neutrophil adhesion. J. Immunol. 156 (1996) 430-433
38. Uff S., Clemetson J.M., Harrison T., Clemetson K.J., and Emsley J. Crystal structure of the platelet glycoprotein Ibα N-terminal domain reveals an unmasking mechanism for receptor activation. J. Biol. Chem. 277 (2002) 35657-35663
39. Riedemann N.C., Guo R.-F., and Ward P.A. Novel strategies for the treatment of sepsis. Nat. Med. 5 (2003) 517-524